Skip to content

Clinical trials

Post-Acute COVID-19 Syndrome trials in Germany with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Phase: Not applicable Country / region: Germany Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20212
20223
20235
20243
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting4
Active, not recruiting2
Not yet recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Schön Klinik Berchtesgadener Land3
Charite University, Berlin, Germany2
Hannover Medical School2
University College, London2
University Hospital Tuebingen2
Eggensberger OHG1
Gaia AG1
Max-Planck-Institute of Psychiatry1
Prof. Dr. Sonia Lippke1
University Medical Center Mainz1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome19
COVID-196
Fatigue4
Cognitive Dysfunction2
Stroke2
Vestibular Diseases2
Communicable Diseases1
Depressive Disorder1
Fatigue Syndrome, Chronic1
Major Depressive Disorder1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.